How could the discussion on interceptor production affect Raytheon's market position?
Raytheon's PAC-2 market share may be affected by US production decisions Since PAC-2 is made by Raytheon, the outcome of this decision could directly influence the company's contract volume and market share. Lockheed Martin is exploring partnerships in Europe, such as with Diehl Defence in Germany, for PAC-3 production, which presents a competitive alternative to Raytheon's PAC-2.
- Effect
- Mixed
- How direct
- Stated in the reporting
- When
- Within weeks
- The story
- Gone quiet
How it reaches Raytheon
-
Jason Reynolds, vice president at Lockheed Martin, stated that the company is considering new industry partnerships to produce PAC-3 Patriot interceptors in Europe. These discussions could also assist Ukraine in meeting its defense needs. Lockheed Martin is willing to discuss PAC-3 production with Ukraine, though U.S. government officials are still deciding between PAC-2, made by Raytheon, or PAC-3. The company also announced an ACE variant, a cheaper interceptor option for Ukraine.
The full event1independent outlet -
During the convention, Lockheed Martin VP Jason Reynolds stated that U.S. government officials are expected to make a decision regarding the production of PAC-2 interceptors, made by Raytheon, or Lockheed’s PAC-3 interceptors. This decision is being weighed against the need to fill shortfalls in Ukraine and the potential for production in Europe.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- militarytimes.com Oct 13
-
defunct American industrial corporation (1922–2020)
Everything about Raytheon
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- U.S. government officials are still expected to make a decision regarding the production of PAC-2 interceptors, made by Raytheon, or Lockheed’s PAC-3.militarytimes.com
- Lockheed is considering partnering with Diehl Defence for eventual PAC-3 production in Germany.militarytimes.com
- Lockheed announced development of an ACE variant, a cheaper option against relatively simple threats, at half the cost of an MSE missile.militarytimes.com
Why it matters
The decision over which interceptor system—PAC-2 or PAC-3—will be prioritized for production outside the United States is critical for the defense industry. For Raytheon, this choice determines the future demand and market share for its PAC-2 product line, especially as global defense needs, such as those in Ukraine, drive production discussions.
This discussion is part of a broader trend of U.S. defense contractors exploring European manufacturing options. Lockheed Martin is looking at countries like Germany, where Raytheon's competitor, Diehl Defence, is already engaged in consultations, indicating a competitive shift in where these critical defense products are being manufactured.
What we don't know yet
- Will the U.S. government prioritize PAC-2 or PAC-3 production in the near term?
- What specific industrial capabilities or parts availability criteria will the U.S. government use in its decision?
What would change this answer
— Other considerations
Beyond this explainer
Questions worth asking
Ideas the web ties closely to this story that the explainer doesn't mention. These are prompts for your own research: Brind hasn't answered them.
-
About Northrop Grumman
How does Northrop Grumman's current defense portfolio compare to the PAC-2 and PAC-3 systems, and how might they benefit from the trend toward European manufacturing?
Explore connected ideas
Each opens in Related concepts: what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Who else could feel it
Other possible ripples from the same event.
Reporting
- militarytimes.comOct 13
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.